| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-03-3754 |
| P698 | PubMed publication ID | 15087410 |
| P2093 | author name string | Zhen Xiao | |
| Timothy D Veenstra | |||
| Asad Umar | |||
| Thomas P Conrads | |||
| Brian T Luke | |||
| Peter Greenwald | |||
| Ernest T Hawk | |||
| Patrick M Lynch | |||
| Sherri Patterson | |||
| Robin K S Phillips | |||
| Iqbal U Ali | |||
| Grant Izmirlian | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2904-2909 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Serum proteomic profiles suggest celecoxib-modulated targets and response predictors | |
| P478 | volume | 64 |
| Q33536646 | Assessment of Protein Stability in Cerebrospinal Fluid Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Protein Profiling |
| Q36570730 | Association of stem-like cells in gender-specific chemoprevention against intestinal neoplasia in MIN mouse |
| Q35053674 | Clinical proteomics: present and future prospects. |
| Q94101610 | Current Awareness on Comparative and Functional Genomics |
| Q33237787 | Finding regions of significance in SELDI measurements for identifying protein biomarkers |
| Q33262623 | Human body fluid proteome analysis |
| Q30987570 | Identification of disease- and therapy-associated proteome changes in the sera of patients with myelodysplastic syndromes and del(5q). |
| Q36180606 | Priorities and standards in pharmacogenetic research |
| Q31125659 | Proteomic patterns as a diagnostic tool for early-stage cancer: a review of its progress to a clinically relevant tool |
| Q33322569 | Serum biomarker profiling by solid-phase extraction with particle-embedded micro tips and matrix-assisted laser desorption/ionization mass spectrometry |
| Q57556800 | Serum proteomics profiling—a young technology begins to mature |
| Q33233126 | The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma |
Search more.